Tuberculosis Vaccine Treatment Market Report

Global Tuberculosis Vaccine Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：225
  • REPORT CODE：GMM841999
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Tuberculosis Vaccine Treatment market report explains the definition, types, applications, major countries, and major players of the Tuberculosis Vaccine Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GreenSignal Bio Pharma

    • China National Biotec Group

    • Bavarian Nordic

    • Taj Pharmaceuticals

    • GlaxoSmithKline

    • Serum Institute of India

    • Merck

    • Japan BCG Lab

    • Sanofi

    • IDT Biologics

    By Type:

    • Immunotherapeutic Vaccines

    • Booster Vaccines

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Tuberculosis Vaccine Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Tuberculosis Vaccine Treatment Outlook to 2028- Original Forecasts

    • 2.2 Tuberculosis Vaccine Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Tuberculosis Vaccine Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Tuberculosis Vaccine Treatment Market- Recent Developments

    • 6.1 Tuberculosis Vaccine Treatment Market News and Developments

    • 6.2 Tuberculosis Vaccine Treatment Market Deals Landscape

    7 Tuberculosis Vaccine Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Tuberculosis Vaccine Treatment Key Raw Materials

    • 7.2 Tuberculosis Vaccine Treatment Price Trend of Key Raw Materials

    • 7.3 Tuberculosis Vaccine Treatment Key Suppliers of Raw Materials

    • 7.4 Tuberculosis Vaccine Treatment Market Concentration Rate of Raw Materials

    • 7.5 Tuberculosis Vaccine Treatment Cost Structure Analysis

      • 7.5.1 Tuberculosis Vaccine Treatment Raw Materials Analysis

      • 7.5.2 Tuberculosis Vaccine Treatment Labor Cost Analysis

      • 7.5.3 Tuberculosis Vaccine Treatment Manufacturing Expenses Analysis

    8 Global Tuberculosis Vaccine Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Tuberculosis Vaccine Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Tuberculosis Vaccine Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Tuberculosis Vaccine Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Tuberculosis Vaccine Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunotherapeutic Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Booster Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tuberculosis Vaccine Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Tuberculosis Vaccine Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.2.2 Canada Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.2 UK Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.3 Spain Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.5 France Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.6 Italy Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.8 Finland Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.9 Norway Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.11 Poland Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.12 Russia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.2 Japan Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.3 India Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.3 Chile Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.6 Peru Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.6.3 Oman Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Tuberculosis Vaccine Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Tuberculosis Vaccine Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Tuberculosis Vaccine Treatment Consumption (2017-2022)

    11 Global Tuberculosis Vaccine Treatment Competitive Analysis

    • 11.1 GreenSignal Bio Pharma

      • 11.1.1 GreenSignal Bio Pharma Company Details

      • 11.1.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.1.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 China National Biotec Group

      • 11.2.1 China National Biotec Group Company Details

      • 11.2.2 China National Biotec Group Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 China National Biotec Group Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.2.4 China National Biotec Group Tuberculosis Vaccine Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bavarian Nordic

      • 11.3.1 Bavarian Nordic Company Details

      • 11.3.2 Bavarian Nordic Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bavarian Nordic Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.3.4 Bavarian Nordic Tuberculosis Vaccine Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Taj Pharmaceuticals

      • 11.4.1 Taj Pharmaceuticals Company Details

      • 11.4.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.4.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 GlaxoSmithKline

      • 11.5.1 GlaxoSmithKline Company Details

      • 11.5.2 GlaxoSmithKline Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 GlaxoSmithKline Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.5.4 GlaxoSmithKline Tuberculosis Vaccine Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Serum Institute of India

      • 11.6.1 Serum Institute of India Company Details

      • 11.6.2 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Serum Institute of India Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.6.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Merck

      • 11.7.1 Merck Company Details

      • 11.7.2 Merck Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Merck Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.7.4 Merck Tuberculosis Vaccine Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Japan BCG Lab

      • 11.8.1 Japan BCG Lab Company Details

      • 11.8.2 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Japan BCG Lab Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.8.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanofi

      • 11.9.1 Sanofi Company Details

      • 11.9.2 Sanofi Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanofi Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.9.4 Sanofi Tuberculosis Vaccine Treatment Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 IDT Biologics

      • 11.10.1 IDT Biologics Company Details

      • 11.10.2 IDT Biologics Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 IDT Biologics Tuberculosis Vaccine Treatment Main Business and Markets Served

      • 11.10.4 IDT Biologics Tuberculosis Vaccine Treatment Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Tuberculosis Vaccine Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Immunotherapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Booster Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Tuberculosis Vaccine Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Tuberculosis Vaccine Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Tuberculosis Vaccine Treatment

    • Figure of Tuberculosis Vaccine Treatment Picture

    • Table Global Tuberculosis Vaccine Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Tuberculosis Vaccine Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Immunotherapeutic Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Booster Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Table North America Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure United States Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure Germany Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure China Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure Brazil Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Tuberculosis Vaccine Treatment Consumption by Country (2017-2022)

    • Figure Australia Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Tuberculosis Vaccine Treatment Consumption and Growth Rate (2017-2022)

    • Table GreenSignal Bio Pharma Company Details

    • Table GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio

    • Table China National Biotec Group Company Details

    • Table China National Biotec Group Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Group Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table China National Biotec Group Tuberculosis Vaccine Treatment Product Portfolio

    • Table Bavarian Nordic Company Details

    • Table Bavarian Nordic Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Bavarian Nordic Tuberculosis Vaccine Treatment Product Portfolio

    • Table Taj Pharmaceuticals Company Details

    • Table Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taj Pharmaceuticals Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table GlaxoSmithKline Tuberculosis Vaccine Treatment Product Portfolio

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio

    • Table Merck Company Details

    • Table Merck Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Merck Tuberculosis Vaccine Treatment Product Portfolio

    • Table Japan BCG Lab Company Details

    • Table Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Japan BCG Lab Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table Sanofi Tuberculosis Vaccine Treatment Product Portfolio

    • Table IDT Biologics Company Details

    • Table IDT Biologics Tuberculosis Vaccine Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table IDT Biologics Tuberculosis Vaccine Treatment Main Business and Markets Served

    • Table IDT Biologics Tuberculosis Vaccine Treatment Product Portfolio

    • Figure Global Immunotherapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Booster Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Tuberculosis Vaccine Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Tuberculosis Vaccine Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US